Medilink North of England News 2019 Medilink NOE News 2019 | Page 12
MANTRA MEDICAL
Medilink North of England is proud to welcome infection
control specialists, Mantra Medical as new members.
The Doncaster based company develop innovative infection
control devices to prevent the spread of everyday, potentially
dangerous infections in hospitals. Mantra Medical
specifically home in on designing infection control that
operates within existing staff workflow patterns, without the
need for any extra work. In a hospital environment, every
patient interaction carries a risk of spreading infection –
particularly with an ageing population and multi-resistant
organisms.
Despite existing infection control measures, Healthcare
Associated Infections (HCAIs) persist – Pulse Oximeters
exemplify the problem of infection control in the current
healthcare environment. They contact nearly all hospital
patients, are a proven vector of infection spread – yet are
almost never cleaned according to evidence.
Existing cleaning procedures for Pulse Oximeters are too
slow, cumbersome and labour-intensive to be performed
between each and every patient – giving infection the
opportunity to spread. The MantraONE device enables
consistent bedside cleaning of Pulse Oximeters between
every patient – eliminating the risk of infection while not
burdening current staff with extra work. Mantra Medical
developed this chemical and mechanical cleaning solution,
which is delivered from a replaceable cartridge inside the
MantraONE, to replicate effective manual cleaning in five
seconds. To learn more visit www.mantramedical.co.uk
MEDILINK LAUNCHES STRATEGIC
PARTNERSHIP WITH CHINESE
LIFE SCIENCE TECHNOLOGY
TRANSFER COMPANY
Medilink is delighted to announce
that it has entered into a strategic
partnership with iBridge in China,
to achieve the mutual goal of fast
tracking the commercialisation
of new technology products in the
Life Science sector, with iBridge
seeking to introduce western health
technology companies to Chinese partners and investors.
iBridge TT International Limited, has outstanding connectivity
within the Life Science sector across China, which includes
medical technology and biotechnology companies, local and
national governments, research academy’s, regulatory agencies,
financial institutions and high net worth individuals.
Speaking on the new partnership, Kevin Kiely said
“Trust is an important element of any partnership and I have
known Tiger Tang, the CEO of iBridge, for over ten years when he
was the former President of the extremely successful Guangzhou
International Biotech Island. I have subsequently got to know
Wah-Hui Chu, the Founder and Chairman of iBridge, who has
held numerous Executive posts around the world, including
the position of President of PepsiCo Beverages in China. I am
confident that iBridge has the expertise and connectivity to open
up lucrative commercial opportunities for our members”.
If you are interested in knowing more about the Medilink / iBridge
partnership and what you need to do to take advantage of this
opportunity, please contact Medilink at
[email protected]
TOOKIE ANNOUNCED AS TITCH INDUSTRY AMBASSADOR
TITCH, (The
Technology
Innovation
Transforming
Child Health)
Network,
a national
healthcare
technology
network and a long-term Tookie
collaborator, has proudly announced
Tookie as an Industry Ambassador.
This initiative has been created to
showcase partnership collaboration
as best practice for both SME’s and the
NHS within innovation and the Medical
Technology development landscape, for
the NIHR and NHS.
As a ‘Healthcare Innovation Business’,
Tookie aims to improve the lives of
12
(CVC) and central lines, while
addressing unmet clinical and patient
needs. The company has designed,
alongside patients, a range of wearable
products in order to address these
needs and create #AlifeMoreNormal
for patients, which is central to the
Tookie brand.
Stephen Tooke, Commercial Director
of Tookie, said: “Our brand is security,
safety and patient reassurance.
Starting in oncology and dialysis,
we’re now venturing into PICC lines,
respiratory and nutrition, because
there is an unmet need, which we aim
to find solutions for in order to help
patients.” Titch will further support
Tookie in the development of new
products and in its NHS adoption
journey.
Joint case studies, including
Tookie’s own NHS adoption
journey, will act as a resource to
SME’s in helping them understand
what steps need to be taken to
successfully release a medical
device or product into the NHS.
TITCH and Tookie believe that this
shared initiative will help support
new and innovative devices, which
is in line with Tookie’s goal of
creating #AlifeMoreNormal for
patients, when starting on the
challenging journey from idea to
NHS Adoption.
For more information, please visit
www.cypmedtech.nihr.ac.uk/titch/
www.tookie.co
#ALifeMoreNormal
12